Kingfisher PLC has announced its weekly share repurchase activity for the period of August 24th to August 28th, 2026, as part of its £300 million share repurchase program. During this week, the company purchased a total of 124,905 ordinary shares from Goldman Sachs International for cancellation, with the volume-weighted average price paid per share being approximately £3.20. The highest price paid was £3.2580 and the lowest was £3.1260. To date, Kingfisher has repurchased 14,906,313 shares under the second tranche of the program.
Kingfisher plc, ISIN: GB0033195214 (the "Company") announces that for the period from 24 August 2026 to 28 August 2026 it purchased for cancellation the following number of ordinary shares of 15 5/7 pence each from Goldman Sachs International ("GSI") as part of its £300 million share repurchase programme announced on 24 March 2026 (the "Programme"). All shares were purchased by the Company from GSI as an "on-exchange" transaction subject to the rules of the London Stock Exchange.
Date of purchase
Number of ordinary shares purchased
Volume weighted average price paid per share (GBP)
Highest price paid per share (GBP)
Lowest price paid per share (GBP)
2026-08-24
24,905
£3.1881
£3.2040
£3.1780
2026-08-25
25,000
£3.2146
£3.2250
£3.1970
2026-08-26
25,000
£3.2389
£3.2580
£3.2180
2026-08-27
25,000
£3.2026
£3.2360
£3.1850
2026-08-28
25,000
£3.1380
£3.1500
£3.1260
To date, the Company has purchased 14,906,313 ordinary shares in aggregate for cancellation from GSI in connection with the second tranche of the Programme. The Company also previously purchased 26,649,016 ordinary shares in aggregate for cancellation from BNP Paribas SA in connection with its execution of the first tranche of the Programme.
A schedule of individual trades carried out by GSI as principal in connection with the above purchases is set out in the link below.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.
